Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Vila M. and Przedborski S. (2004) Genetic clues to the pathogenesis <strong>of</strong> Park<strong>in</strong>son’s disease.<br />
244<br />
Nat. Med. 10, S58–S62.<br />
V<strong>in</strong>gerhoets F. J., Snow B. J., Lee C. S., Schulzer M., Mak E. and Calne D. B. (1994) Longitud<strong>in</strong>al<br />
fluorodopa positron emission tomographic studies <strong>of</strong> the evolution <strong>of</strong> idiopathic<br />
park<strong>in</strong>sonism. Ann Neurol. 36, 759–764.<br />
Volles M. J., Lee S. J., Rochet J. C., Shtilerman M. D., D<strong>in</strong>g T. T., Kessler J. C., Lansbury Jr. P. T.<br />
(2001) Vesicle permeabilization by prot<strong>of</strong>ibrillar alpha-synucle<strong>in</strong>: implications for the<br />
pathogenesis and treatment <strong>of</strong> Park<strong>in</strong>son's disease. Biochemistry 40, 7812–7819.<br />
Von Campenhausen, Bornsche<strong>in</strong> B., Wick R., Bötzel K., Sampaio C., Poewe W., Oertel W.,<br />
Siebert U., Berger K. and Dodel R. (2005) Prevalence and <strong>in</strong>cidence <strong>of</strong> Park<strong>in</strong>son’s disease<br />
<strong>in</strong> Europe. Eur. Neuropsychopharmacol. 15, 473–490.<br />
Von Coelln R., Thomas B., Savitt J. M., Lim K. L., Sasaki M., Hess E. J., Dawson V. L. and Dawson<br />
T. M. (2004) Loss <strong>of</strong> locus coeruleus neurons and reduced startle <strong>in</strong> park<strong>in</strong> null mice. Proc.<br />
Natl. Acad. Sci. U. S. A. 101, 10744–10749.<br />
Vroegop S. M., Decker D.E. and Buxser S. E. (1995) Localization <strong>of</strong> damage <strong>in</strong>duced by reactive<br />
oxygen species <strong>in</strong> cultured cells. Free Radic. Biol. Med. 18, 141–151.<br />
Vyas I., Heikkila R. E. and Nicklas W. J. (1986) Studies on the <strong>neurotoxicity</strong> <strong>of</strong> 1-methyl-4-<br />
phenyl-1,2,3,6-tetrahydropyrid<strong>in</strong>e: <strong>in</strong>hibition <strong>of</strong> NADH-l<strong>in</strong>ked substrate oxidation by its<br />
metabolite 1-methyl-4-phenylpyrid<strong>in</strong>ium. J. Neurochem. 46, 1501–1507.<br />
Wagner W. (1999) Canadian M<strong>in</strong>erals Yearbook. Natural Resources Canada, Ottawa, Ontario,<br />
Canada.<br />
Wakabayashi K. and Takahashi H. (1997) Neuropathology <strong>of</strong> autonomic nervous system <strong>in</strong><br />
Park<strong>in</strong>son's disease. Eur Neurol. 38, 2–7.<br />
Wakabayashi K., Tanji K., Mori F. and Takahashi H. (2007) The Lewy body <strong>in</strong> Park<strong>in</strong>son's<br />
disease: molecules implicated <strong>in</strong> the formation and degradation <strong>of</strong> alpha-synucle<strong>in</strong><br />
aggregates. Neuropathology 27, 494–506.